Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD)
Completed · Phase 2 · Has a placebo group
Conditions studied: Hypertriglyceridemia, Cardiovascular Diseases
In brief
This was a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the safety, including tolerability, of ISIS 678354 and to assess the efficacy of different doses and dosing regimens of ISIS 678354 for reduction of serum triglyceride (TG) levels in participants with hypertriglyceridemia and established CVD or at a high risk for CVD.
Key facts
- Study ID
- NCT03385239
- Run by
- Akcea Therapeutics
- People needed
- 114
- Starts
- 2018-01-30
- Expected to finish
- 2020-02-25
- Last updated by the study team
- 2023-01-11
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Clinical Site — Cottonwood, Arizona, United States
- Clinical Site — Little Rock, Arkansas, United States
- Clinical Site — Carmichael, California, United States
- Clinical Site — Fresno, California, United States
- Clinical Site — La Jolla, California, United States
- Clinical Site — Long Beach, California, United States
- Clinical Site — Montclair, California, United States
- Clinical Site — Wilmington, Delaware, United States
- Clinical Site — Boca Raton, Florida, United States
- Clinical Site — Jacksonville, Florida, United States
- Clinical Site — New Port Richey, Florida, United States
- Clinical Site — Munster, Indiana, United States
- Clinical Site — Ames, Iowa, United States
- Clinical Site — Kansas City, Kansas, United States
- Clinical Site — Louisville, Kentucky, United States
- Clinical Site — Fall River, Massachusetts, United States
- Clinical Site — Cooperstown, New York, United States
- Clinical Site — High Point, North Carolina, United States
- Clinical Site — Portland, Oregon, United States
- Clinical Site — Lansdale, Pennsylvania, United States
- Clinical Site — Providence, Rhode Island, United States
- Clinical Site — Greer, South Carolina, United States
- Clinical Site — Houston, Texas, United States
- Clinical Site — Milwaukee, Wisconsin, United States
- Clinical Site — Cambridge, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.